A Preview Of Editas Medicine's Earnings
Portfolio Pulse from Benzinga Insights
Editas Medicine (NASDAQ:EDIT) is set to release its latest quarterly earnings report on November 3, 2023. Analysts estimate an earnings per share (EPS) of $-0.57. The company's past performance shows a pattern of beating EPS estimates, which often leads to an increase in share price. However, the stock has been down 38.26% over the last 52-week period.
November 02, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Editas Medicine is expected to report an EPS of $-0.57. The company has a history of beating EPS estimates, which could potentially lead to a short-term increase in share price. However, the stock has been down 38.26% over the last year.
The company's earnings report is a key event that could impact its stock price. While the company has a history of beating EPS estimates, which could lead to a short-term increase in share price, the overall trend for the stock has been negative over the past year. This suggests that there are other factors at play affecting the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100